Thankyou for your reply. Yes invested for the long term and buy at these levels when I can is an excellent opportunity to be able to accumulate for when the eventual appreciation in sp is realised multiple. More than happy for it to be the only speculative play for me atm as risk is spread over the multiple prospects achieving excellent results both in the lab and clinical. Because the DEP tech is so incredible and spl have so many patients for its uses both existing drugs off patient and new developing in partnership. Too detailed and too many to list here by me but the earnings capacity is phenomenal imo. So no pain point for me. I’m not a trader. I’m invested here for the long haul. No real timeframes as, drug development has always taken many years to go from the lab to clinical use. SPL has candidates that stack up most promising well advanced enough to virtually take out the speculative risk for me.
SPL Price at posting:
$1.03 Sentiment: Buy Disclosure: Held
